Bastien P, Saliou P, Gentilini M
Service de Médecine de l'Hôpital Central de Port-Vila, Vanuatu.
Bull Soc Pathol Exot Filiales. 1988;81(2):226-37.
Chloroquine resistance of P. falciparum was studied in Vanuatu from March 1981 to July 1984, with limited means, and a non-systematic procedure; it was first evidenced in 1980. In vivo chloroquine resistance criteria were those established by W. H. O. In vitro testing methods were the standard W. H. O. macro-test and micro-test. 124 in vivo chloroquine resistant cases were seen: 111 cases in hospital (63 R III, 28 R II and 20 R I) and 13 cases in field studies (1 R III, 4 R II and 8 R I). 87 in vitro chloroquine sensitivity tests were carried out. A high failure rate was apparently due to a defective batch of lyophilised culture medium. Out of the 25 isolates successfully tested, 22 showed in vitro chloroquine resistance (88%). Correlation between in vivo and in vitro resistance was good in 13 cases studied by both methods. Moreover, 13 in vitro mefloquine sensitivity tests evidenced a high sensitivity to this drug. Chloroquine resistant malaria thus appears to be extended to the whole country. Its prevalence remains unknown but was estimated at 60% at least in 1984. Moreover, a geographical spread of chloroquine resistance from north to south of the group was evidenced between 1980 and 1984, identical to that of the dramatic increase of P. falciparum incidence at the same period of time. Possible mechanisms of the advent of chloroquine resistance in Vanuatu are discussed.
1981年3月至1984年7月,在瓦努阿图采用有限的手段和非系统的程序对恶性疟原虫的氯喹耐药性进行了研究;1980年首次发现氯喹耐药性。体内氯喹耐药性标准是由世界卫生组织制定的。体外检测方法是世界卫生组织标准的宏观检测和微观检测。共观察到124例体内氯喹耐药病例:111例在医院(63例为R III型,28例为R II型,20例为R I型),13例在现场研究中(1例为R III型,4例为R II型,8例为R I型)。进行了87次体外氯喹敏感性试验。高失败率显然是由于一批冻干培养基有缺陷。在成功检测的25株分离株中,22株显示体外氯喹耐药(88%)。通过两种方法研究的13例病例中,体内和体外耐药性之间的相关性良好。此外,13次体外甲氟喹敏感性试验证明对该药高度敏感。因此,氯喹耐药性疟疾似乎已蔓延至全国。其流行率仍然未知,但估计在1984年至少为60%。此外,1980年至1984年期间,证明了氯喹耐药性在该群岛从北向南的地理扩散,这与同期恶性疟原虫发病率的急剧上升情况相同。文中讨论了瓦努阿图出现氯喹耐药性的可能机制。